Medicines

  1. Where data and humanity meet: an algorithm to improve medicine pricing models

    Industry NewsHow two professors imagine a better world for stakeholders in the medical industry. 

    Read more »
  2. What happens between availability and approval of medicines?

    TimeUnderstand why approval doesn’t necessarily mean availability and what you can do if a medicine is approved, but not available in your country.

    Read more »
  3. Chinese ‘Buyers Club’ shines a light on access delays

    Industry News‘Dying to Survive’ was an unlikely blockbuster, documenting the plight of a leukemia patient who puts himself at risk to import costly cancer drugs for himself and his fellow countrymen.

    Read more »
  4. Kisqali (ribociclib) approved for additional indications in HR+/HER2- advanced breast cancer

    News updateKisqali is now the only CDK4/6 inhibitor for use with an aromatase inhibitor for the treatment of pre-, peri- or postmenopausal women in the US.

    Read more »
  5. Erenumab (Aimovig) now approved for the European Union

    The new preventive medicine for migraine Aimovig (erenumab) has been approved by the EMA. Read more...
    Breaking News 

    Read more »
  6. In-depth review of the new EMA-approved preventative migraine injection

    The approval marks a significant advance in the field of neurology — and one that migraine patients will no doubt welcome.

    News update


    Read more »
  7. 10 important facts to know about the new migraine injection

    You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

    Glasses

    Read more »
  8. A new answer for treating migraines?

    7 need-to-knows about migraine as well as some updates on the latest treatment developments

    Blog post

    Read more »
  9. Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations

    Industry News

    Read more »
  10. FDA grants accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for metastatic colorectal cancer

    Industry News

    Read more »
Posts loader